May 21-23, 2024,
Steigenberger Wiltcher's, Brussels
Join White & Case at EU Pharmaceutical Law Forum 2024
You're Invited to EU Pharma Law with an Exclusive 10% Off
We are excited to announce that White & Case will be participating at the EU Pharmaceutical Law Forum on 21-23 May 2024 at the Steigenberger Wiltcher's Hotel, Brussels. And, we are pleased to let you know that as a valued client of White & Case, we have an exclusive 10% discount* for you. Your VIP discount code is: P24WHITECASE
*T&C's Apply
Regulatory Scrutiny on Deals: Update on Foreign Direct Investment Screening
Growth of protectionist policies internationally and their impact for pharmaceutical commercial transactions and collaborations
Avoiding delays: knowledge on national requirements for the disclosure of knowledge and of supply chain management issues
PRESENTED BY:
TRI DIALOGUE Key Developments at the Intersection of Antitrust and Intellectual Property
Implications of the Teva/Copaxone case and Novartis case on unilateral conduct and divisional strategies for IP and reg exclusivities
Potential implications if the EU Commission adopt a new theory of harm
Implications from the Servier case: where are we with patent settlements and practical guidance on managing antitrust risk
PRESENTED BY:
DUAL DIALOGUE Success Factors for Licensing Life Science Deals
Discussing the more challenging, yet common risks in license collaboration, true JVs, M&A and investment deals
Key market insight: what are killing commercial deals? Changing case law and emerging risks
Areas of risk: operational behavior preceding the deal and practical things that crop up during and after the deals